Total Funding
$82.2M
Employee Range
1-10
A startup developing AntagomiR oligonucleotides for Myotonic Dystrophy patients. Creating a new treatment option to improve patient outcomes.
ARTHEx Biotech data powered by:
Share
ARTHEx Biotech data powered by:
ARTHEx BiotechOverall Ranking
Regional Rank
Share
Loading...
In Western Europe
Top null%out of startups
ARTHEx BiotechIndustry Rankings in
Healthtech
City Rank
Share
5th
In Valencia
Top 34%out of 15 startups
National Rank
Share
45th
In Spain
Top 8%out of 600 startups
Regional Rank
Share
748th
In Western Europe
Top 17%out of 4551 startups
ARTHEx BiotechSubindustry Rankings in
BiotechnologyCity Rank
Share
2nd
In Valencia
Top 67%out of 3 startups
National Rank
Share
15th
In Spain
Top 14%out of 110 startups
Regional Rank
Share
294th
In Western Europe
Top 18%out of 1726 startups
rankings by:
ARTHEx BiotechSB Rank Evolution
Not enough data points to display the chart.
ARTHEx BiotechstartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro